• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by ObsEva SA (Amendment)

    2/14/23 4:18:58 PM ET
    $OBSV
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $OBSV alert in real time by email
    SC 13G/A 1 d428170dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 5)

     

     

    ObsEva SA

    (Name of Issuer)

    Common Shares, par value CHF 1/13 per share

    (Title of Class of Securities)

    H5861P103

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐

    Rule 13d-1(b)

     

      ☐

    Rule 13d-1(c)

     

      ☒

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP NO. H5861P103    13 G   

     

      1    

      NAMES OF REPORTING PERSONS

     

      Ernest Loumaye

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Belgium

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5     

      SOLE VOTING POWER

     

      3,023,557(1)

       6   

      SHARED VOTING POWER

     

      0

       7   

      SOLE DISPOSITIVE POWER

     

      3,023,557(1)

       8   

      SHARED DISPOSITIVE POWER

     

      0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      3,023,557(1)

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      2.8%(2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

    (1)

    Includes 1,023,557 shares issuable upon exercise of options which are exercisable within 60 days of December 31, 2022.

    (2)

    This percentage is calculated based on 107,706,699 Common Shares outstanding as of December 31, 2022 as reported by the Issuer to the Reporting Person.


    CUSIP NO. H5861P103    13 G   

     

    Introductory Note: This statement on Schedule 13G/A is filed on behalf of the Reporting Person, in respect of Common Shares (“Common Shares”) of ObsEva SA (the “Issuer”).

     

    Item 1(a)

    Name of Issuer:

    ObsEva SA

     

    Item 1(b)

    Address of Issuer’s principal executive offices:

    Chemin des Aulx, 12

    1228 Plan-les-Ouates

    Geneva, Switzerland

     

    Items 2(a)     Name

    of Reporting Persons filing:

    Ernest Loumaye

     

    Item 2(b)

    Address or principal business office or, if none, residence:

    The address of the principal business office of Mr. Loumaye is c/o ObsEva SA, Chemin des Aulx, 12, 1228 Plan-les-Ouates, Geneva, Switzerland

     

    Item 2(c)

    Citizenship:

     

    Name

      

    Citizenship or Place of Organization

    Ernest Loumaye        Belgium

    Item 2(d)      Title of class of securities:

    Common Shares, par value CHF 1/13 per share

     

    Item 2(e)     CUSIP

    No.:

    H5861P103

     

    Item 3

    If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filings is a:

    Not applicable.

     

    Item 4

    Ownership

    The following information with respect to the ownership of Common Shares of the Issuer by the Reporting Person filing this statement on Schedule 13G is provided as of December 31, 2022.

     

    Reporting Persons

       Common
    Shares Held
    Directly
        Sole Voting
    Power
        Shared
    Voting
    Power
         Sole
    Dispositive
    Power
        Shared
    Dispositive
    Power
         Beneficial
    Ownership
        Percentage
    of Class
    (1)
     

    Ernest Loumaye

         3,023,557 (1)      3,023,557 (1)      0        3,023,557 (1)      0        3,023,557 (1)      2.8 %(2) 

     

    (1)

    Includes 1,023,557 shares issuable upon exercise of options which are exercisable within 60 days of December 31, 2022.

    (2)

    This percentage is calculated based on 107,706,699 Common Shares outstanding as of December 31, 2022 as reported by the Issuer to the Reporting Person.

     

    Item 5

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☒


    CUSIP NO. H5861P103    13 G   

     

    Item 6

    Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

     

    Item 7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Not applicable.

     

    Item 8

    Identification and Classification of Members of the Group

    Not applicable.

     

    Item 9

    Notice of Dissolution of Group

    Not applicable.

     

    Item 10

    Certifications

    Not applicable.


    CUSIP NO. H5861P103    13 G   

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 14, 2023

     

    By:  

    /s/ Ernest Loumaye

      Ernest Loumaye
    Get the next $OBSV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OBSV

    DatePrice TargetRatingAnalyst
    8/30/2022Buy → Neutral
    H.C. Wainwright
    6/3/2022$6.00Overweight
    Cantor Fitzgerald
    4/26/2022$12.00Buy
    Canaccord Genuity
    3/28/2022$12.00Buy
    Aegis Capital
    11/29/2021$17.00 → $15.00Buy
    HC Wainwright & Co.
    More analyst ratings